ProCE Banner Activity

COVID-19 时代的 HIV 护理:弥补大流行服务减少期间造成的损失

Text Module

在同事之间的这次电话会议中,阅读专家教师讨论,了解他们在 COVID-19 大流行期间掌握到超过 18 个月的停工和医疗服务提供限制的长期后果,特别是关于错过预防和心理保健服务的内容。您将阅读他们关于让 PWH 返回诊所就诊,以“追赶”积压服务的重要性的想法。

Released: February 11, 2022

Expiration: February 10, 2023

Share

Faculty

Joseph J. Eron

Joseph J. Eron, Jr., MD

Professor of Medicine
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

吉利德科学公司;Janssen Products, LP 旗下的 Janssen Therapeutics;默沙东公司

Gilead

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Merck Sharp & Dohme Corp.

Learning Objectives

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Faculty Disclosure

Primary Author

Joseph J. Eron, Jr., MD

Professor of Medicine
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Joseph J. Eron, Jr.,医学博士,他已收到 Gilead Sciences、Janssen、Merck、Trio Health 和 ViiV 的咨询费以及 Gilead Sciences、Janssen 和 ViiV 的研究支持资金。

Staff Disclosure

Staff

Jennifer M. Blanchette, Ph.D.

Clinical Editor
Clinical Care Options, LLC

Jennifer M. Blanchette,博士,没有相关的利益冲突要报告。

Edward King, M.A.

Vice President, Editorial
Clinical Care Options, LLC

Edward King,文学硕士,没有相关的利益冲突要报告。

Margaret McLaughlin, PhD

Margaret McLaughlin,博士,没有相关的利益冲突要报告。

Zachary Schwartz, MSc, ELS

Scientific Director

Zachary Schwartz,理学硕士,ELS,没有相关的利益冲突要报告。

Julie Skowronski, FNP-BC

Julie Skowronski,FNP-BC,没有相关的利益冲突要报告。

Jennifer Swanson, MEd

Associate Managing Editor, Hematology/Oncology
Clinical Care Options, LLC

Jennifer Swanson(药学博士)没有要报告的相关利益冲突。

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.